HomeIJF • FRA
add
ICON PLC
Previous close
€169.10
Day range
€169.45 - €169.45
Year range
€169.45 - €316.30
Market cap
15.09B USD
Avg Volume
171.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.04B | -1.22% |
Operating expense | 250.70M | -27.23% |
Net income | 260.00M | 20.14% |
Net profit margin | 12.74 | 21.68% |
Earnings per share | 3.43 | -0.87% |
EBITDA | 447.92M | 5.40% |
Effective tax rate | -4.58% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 538.78M | 41.76% |
Total assets | 16.88B | -0.66% |
Total liabilities | 7.35B | -5.09% |
Total equity | 9.52B | — |
Shares outstanding | 80.76M | — |
Price to book | 1.43 | — |
Return on assets | 5.15% | — |
Return on capital | 6.62% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 260.00M | 20.14% |
Cash from operations | 338.31M | -23.13% |
Cash from investing | -68.88M | 43.77% |
Cash from financing | -403.96M | -58.08% |
Net change in cash | -156.72M | -340.97% |
Free cash flow | 299.93M | 8.28% |
About
ICON plc is an Irish headquartered multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. The company is listed on the Nasdaq stock exchange in the United States, and As of June 2023 had approximately 41,160 employees in 108 locations spread across 53 countries. Wikipedia
CEO
Founded
1990
Website
Employees
41,900
